Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	5246.57	-120.46	2.25
Graham Fair Price	-82.86	0.33	1.91
PEG	25278.81	0.21	< 0.005
Price/Book	-28.32	7.24	10.10
Price/Cash Flow	36.79	-30.92	-48.92
Prices/Earnings	3154.94	-21.63	0.66
Price/Sales	154.05	70.61	27.80
Price/FCF	36.79	-30.92	-48.92
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-27.99	0.05	0.07
Operating Margin	-94.99	-0.80	16.02
ROA	-97.82	-0.03	1.23
ROE	3.80	-0.08	-97.80
ROIC	1.77	-0.03	-98.32
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	-0.80	99.61
Dividends QOQ	5209.59	0.59	-99.99
EBIT QOQ	17.51	-1.01	-94.22
EPS QOQ	7.94	-1.02	-87.17
FCF QOQ	-3.05	-0.05	98.48
Revenue QOQ	0.42	-0.74	76.13
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	14.19	10.63	-25.10
Days Sales Outstanding (DSO)	247.23	392.27	58.67
Inventory Turnover	6.34	8.47	33.51
Debt/Capitalization	0.62	0.64	2.91
Quick Ratio	2.58	3.15	22.05
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	0.21	0.24	15.48
Cash	0.05	0.18	260.52
Capex	< 0.005	< 0.005	-46.63
Free Cash Flow	-0.04	-0.06	-30.96
Revenue	0.08	0.02	-67.42
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.71	3.20	18.23
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	0.28	-15.67	5442.62
Naive Interpretation	Member

06 - Financial Health · Bad

Rating